Cargando…
Prevention of tumor metastasis formation by anti-variant CD44
A splice variant of CD44 (CD44v) originally discovered on metastases of a rat pancreatic adenocarcinoma (BSp73ASML) has been shown by transfection to confer metastatic behavior to nonmetastatic tumor cells (Gunthert U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H....
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190906/ https://www.ncbi.nlm.nih.gov/pubmed/8426113 |
Ejemplares similares
-
Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice
por: Gerardo-Ramírez, Monserrat, et al.
Publicado: (2023) -
Expression of CD44 Variant Exons 8–10 in Colorectal Cancer and Its Relationship to Metastasis
por: Takeuchi, Kazuo, et al.
Publicado: (1995) -
Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis
por: Orian-Rousseau, Véronique
Publicado: (2015) -
A Novel Anti-CD44 Variant 3 Monoclonal Antibody C(44)Mab-6 Was Established for Multiple Applications
por: Suzuki, Hiroyuki, et al.
Publicado: (2023)